Due to the COVID-19 pandemic outbreak, Shenzhen Uni-medica has worked extensively to develop the new one step multiplex real-time RT-PCR reagent kit to allow laboratories to diagnose the disease caused by 2019-nCov infection with fast and easy to use assays. Shenzhen Uni-medica RT PCR detection kit is a fast, highly sensitive multiplex diagnostic kit that contains both the assays and controls needed for the real-time PCR detection of RNA from the 2019-nCov.
Shenzhen Uni-medica RT PCR test Kit, adopting fluorescence PCR technology, is used for in vitro qualitative DNA detection of novel coronavirus 2019-nCoV in respiratory specimens including oropharyngeal nasopharyngeal swab, sputum, and bronchoalveolar lavage fluid.
Shenzhen Uni-medica RT PCR testing Kit has the features below:
High Sensitivity: Limit of detection is 200 copies/ml
Internal Control: The whole process is monitored by internal control;
Flexibility: Compatible with multiple brands of Real Time PCR systems.
Shenzhen Uni-medica Technology Co., Ltd (Uni-medica) is a national high-tech enterprise. It has established cooperation and jointly performed a number of scientific research projects with the Hong Kong University of Science and Technology, Shenzhen University and Chinese Academy of Sciences. Uni-medica was also selected as one of the top 100 new Chinese innovative enterprises. The company takes the technical innovation of molecular detection methods as the core driving force, and focuses on the R&D and industrialization of Molecular diagnostic products aiming at prevention and control of infectious diseases and genetic diseases.